Keith G Heinzerling

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence
    Keith G Heinzerling
    UCLA Center for Behavioral and Addiction Medicine, Department of Family Medicine, University of California, Los Angeles, CA 90095, USA
    J Adolesc Health 52:502-5. 2013
  2. pmc Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence
    Keith G Heinzerling
    Department of Family Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Drug Alcohol Depend 109:20-9. 2010
  3. pmc Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use
    Keith G Heinzerling
    Department of Family Medicine and Substance Abuse Pharmacotherapy Unit, University of California Los Angeles, Los Angeles, California 90095, USA
    Gend Med 9:112-20. 2012
  4. pmc Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute, 760 Westwood Plaza, Box 951759, Los Angeles, CA 90095, USA
    Drug Alcohol Depend 105:48-55. 2009
  5. pmc Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
    Steven Shoptaw
    Department of Family Medicine, David Geffen School of Medicine at UCLA, 10880 Wilshire Boulevard, Suite 540, Los Angeles, CA 90095, USA
    Drug Alcohol Depend 96:222-32. 2008
  6. ncbi request reprint Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence
    Steve Shoptaw
    S David Geffen School of Medicine at UCLA, Department of Family Medicine, 10880 Wilshire Boulevard, Suite 540, Los Angeles, CA 90095, USA
    J Addict Dis 27:13-23. 2008
  7. pmc Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment
    Matthew Brensilver
    Department of Family Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA
    Drug Alcohol Rev 32:96-9. 2013
  8. ncbi request reprint Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence
    Matthew Brensilver
    Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Exp Clin Psychopharmacol 20:430-5. 2012
  9. ncbi request reprint Pharmacotherapy of amphetamine-type stimulant dependence: an update
    Matthew Brensilver
    Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA
    Drug Alcohol Rev 32:449-60. 2013
  10. pmc A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation
    Matthew Brensilver
    Department of Family Medicine, David Geffen School of Medicine at UCLA, CA 90095, USA
    Drug Alcohol Depend 125:169-72. 2012

Detail Information

Publications11

  1. pmc Pilot randomized trial of bupropion for adolescent methamphetamine abuse/dependence
    Keith G Heinzerling
    UCLA Center for Behavioral and Addiction Medicine, Department of Family Medicine, University of California, Los Angeles, CA 90095, USA
    J Adolesc Health 52:502-5. 2013
    ..To perform a pilot clinical trial of bupropion for methamphetamine abuse/dependence among adolescents...
  2. pmc Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence
    Keith G Heinzerling
    Department of Family Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Drug Alcohol Depend 109:20-9. 2010
    ..To compare modafinil to placebo for reducing methamphetamine (MA) use, improving retention, and reducing depressive symptoms and MA cravings. Rates of adverse events and cigarette smoking with modafinil versus placebo were also compared...
  3. pmc Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use
    Keith G Heinzerling
    Department of Family Medicine and Substance Abuse Pharmacotherapy Unit, University of California Los Angeles, Los Angeles, California 90095, USA
    Gend Med 9:112-20. 2012
    ..Estrogen increases expression of brain-derived neurotrophic factor (BDNF), which has effects on MA-induced striatal dopamine release and protects against MA-induced neurotoxicity...
  4. pmc Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables
    Andy C Dean
    Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute, 760 Westwood Plaza, Box 951759, Los Angeles, CA 90095, USA
    Drug Alcohol Depend 105:48-55. 2009
    ..On the basis of these findings, we recommend that research groups seeking to identify new predictors of treatment outcome compare the predictors to methamphetamine usage variables to assure that unique predictive power is attained...
  5. pmc Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
    Steven Shoptaw
    Department of Family Medicine, David Geffen School of Medicine at UCLA, 10880 Wilshire Boulevard, Suite 540, Los Angeles, CA 90095, USA
    Drug Alcohol Depend 96:222-32. 2008
    ..A secondary objective compared bupropion to placebo for reducing cigarette smoking among MA dependent participants...
  6. ncbi request reprint Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence
    Steve Shoptaw
    S David Geffen School of Medicine at UCLA, Department of Family Medicine, 10880 Wilshire Boulevard, Suite 540, Los Angeles, CA 90095, USA
    J Addict Dis 27:13-23. 2008
    ..The failure to find an effect for bupropion relative to placebo, when combined with standard cognitive behavioral therapy, dampens enthusiasm for future development of bupropion as a cocaine pharmacotherapy...
  7. pmc Cigarette smoking as a target for potentiating outcomes for methamphetamine abuse treatment
    Matthew Brensilver
    Department of Family Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA
    Drug Alcohol Rev 32:96-9. 2013
    ..Cigarette smoking occurs frequently among individuals with methamphetamine (MA) dependence. Preclinical and clinical evidence has suggested that the common co-abuse of MA and cigarettes represents a pharmacologically meaningful pattern...
  8. ncbi request reprint Placebo-group responders in methamphetamine pharmacotherapy trials: the role of immediate establishment of abstinence
    Matthew Brensilver
    Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Exp Clin Psychopharmacol 20:430-5. 2012
    ..The majority of information regarding response in the placebo group from a 12-week trial is obtained early in the trial...
  9. ncbi request reprint Pharmacotherapy of amphetamine-type stimulant dependence: an update
    Matthew Brensilver
    Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles, USA
    Drug Alcohol Rev 32:449-60. 2013
    ..Behavioural treatments are efficacious, but their impact is limited underscoring the need for other treatment options, notably, pharmacotherapy...
  10. pmc A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation
    Matthew Brensilver
    Department of Family Medicine, David Geffen School of Medicine at UCLA, CA 90095, USA
    Drug Alcohol Depend 125:169-72. 2012
    ..These data provide estimates of the duration of treatment and the degree of responsiveness required to persist in bupropion treatment...
  11. ncbi request reprint Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence
    Keith G Heinzerling
    Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, USA
    Drug Alcohol Depend 85:177-84. 2006
    ..To conduct a 16-week, randomized, placebo-controlled, double-blind trial of two GABAergic medications, baclofen (20 mg tid) and gabapentin (800 mg tid), for the treatment of methamphetamine dependence...